
Out in @BloodJournal our review on “T cell lymphomas in CAR-T recipients: assessing risks and causalities.” One year after the initial FDA notice. The data is reassuring regarding safety. Here is link for free access through end of January. doi.org/10.1182/blood.…
English




















